- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06308432
Sweat Rate Measurement With a Sensor (Wearable) in Different Climatic Conditions With Road Cyclists. (CYSU)
Study Overview
Status
Conditions
Detailed Description
Subjects who meet the inclusion criteria will be recruited to participate in the clinical trial and perform the exercise sessions.
The cyclists in the study will have to make 7 visits to the laboratory. At the first visit, their aerobic performance will be evaluated by an incremental test to exhaustion with gas analysis. And in the next 6 visits they will have to perform a sustained intensity exercise with different environmental conditions according to the combination of temperature, humidity and intensity.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Murcia, Spain, 30107
- Catholic University of Murcia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male cyclists with more than two years of cycling experience.
- Perform tests without fatigue.
- Road bike training at least twice a week.
Exclusion Criteria:
- Participants with chronic illness.
- Have a long-term injury that prevents you from training in the previous month.
- Inability to understand informed consent.
- Use of diuretics in the month prior to or during the measurement period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 22 degrees, 40% humidity and 50% intensity
The room in which the 30-minute test will be performed will be at 22 degrees Celsius and 40% humidity. The subject should perform the test at 50% of the power at which he reached his VO2max. |
The subject will perform the 30-minute test at an intensity of 50% of the power at which he/she has reached his/her VO2max.
The performance test will be carried out in a room conditioned to a temperature of 22º.
The performance test will be carried out in a room conditioned to 40% humidity.
|
|
Experimental: 35 degrees, 40% humidity and 50% intensity
The room in which the 30-minute test will be performed will be at 35 degrees Celsius and 40% humidity. The subject should perform the test at 50% of the power at which he reached his VO2max. |
The subject will perform the 30-minute test at an intensity of 50% of the power at which he/she has reached his/her VO2max.
The performance test will be carried out in a room conditioned to 40% humidity.
The performance test will be carried out in a room conditioned to a temperature of 35º.
|
|
Experimental: 35 degrees, 65% humidity and 50% intensity
The room in which the 30-minute test will be performed will be at 35 degrees Celsius and 65% humidity. The subject should perform the test at 50% of the power at which he reached his VO2max. |
The subject will perform the 30-minute test at an intensity of 50% of the power at which he/she has reached his/her VO2max.
The performance test will be carried out in a room conditioned to a temperature of 35º.
The performance test will be carried out in a room conditioned to 65% humidity.
|
|
Experimental: 22 degrees, 40% humidity and 60% intensity
The room in which the 30-minute test will be performed will be at 22 degrees Celsius and 40% humidity. The subject should perform the test at 60% of the power at which he reached his VO2max. |
The performance test will be carried out in a room conditioned to a temperature of 22º.
The performance test will be carried out in a room conditioned to 40% humidity.
The subject will perform the 30-minute test at an intensity of 60% of the power at which he/she has reached his/her VO2max.
|
|
Experimental: 35 degrees, 40% humidity and 60% intensity
The room in which the 30-minute test will be performed will be at 35 degrees Celsius and 40% humidity. The subject should perform the test at 60% of the power at which he reached his VO2max. |
The performance test will be carried out in a room conditioned to 40% humidity.
The performance test will be carried out in a room conditioned to a temperature of 35º.
The subject will perform the 30-minute test at an intensity of 60% of the power at which he/she has reached his/her VO2max.
|
|
Experimental: 35 degrees, 65% humidity and 60% intensity
The room in which the 30-minute test will be performed will be at 35 degrees Celsius and 65% humidity. The subject should perform the test at 60% of the power at which he reached his VO2max. |
The performance test will be carried out in a room conditioned to a temperature of 35º.
The performance test will be carried out in a room conditioned to 65% humidity.
The subject will perform the 30-minute test at an intensity of 60% of the power at which he/she has reached his/her VO2max.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sweat
Time Frame: Change of baseline rate of sweet rate in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
The amount of sweat will be measured by a sensor placed on the back.
|
Change of baseline rate of sweet rate in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microcapillary Blood
Time Frame: Change of baseline rate of sweet rate in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
By means of a lancet puncture in the thumb of the finger, 70 ml of capillary blood will be extracted.This test provides biochemical variables (ABL90FLEX) with 70 ml of capillary blood.
|
Change of baseline rate of sweet rate in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
|
Heart Rate
Time Frame: Changes of heart rate in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
The heart rate will be evaluated by means of a heart rate strap.
|
Changes of heart rate in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
|
Fatigue
Time Frame: Change of fatigue in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
Rate of perceived exertion using Borg scale.
En esta escala 0 representa nada fatigado y el 10 esfuerzo máximo.
|
Change of fatigue in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
|
Temperature on the forehead
Time Frame: Changes in Temperature on the forehead in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
The temperature will be measured by an infrared thermometer.
|
Changes in Temperature on the forehead in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
|
Temperature in the ear
Time Frame: Changes in Temperature in the ear in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
The temperature will be measured by ear thermometer.
|
Changes in Temperature in the ear in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
|
Sleep efficiency
Time Frame: Changes in the sleep efficiency in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
Measured by accelerometry, with Actigraph wGT3X-BT
|
Changes in the sleep efficiency in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
|
Karolinska drowsiness scale
Time Frame: It will be measured the day after in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
Measured by Karolinska test
|
It will be measured the day after in six occasions (the first day, day 7, day, 14, day 21, day 28, day 35)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UCAMCFE-00036
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sweat
-
University of Arkansas, FayettevilleNot yet recruitingHeat Effect | Sweat Rate | Sweat Sodium Concentration
-
PepsiCo Global R&DRecruitingNormative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female AthleteSweat RateUnited States
-
University of Arkansas, FayettevilleCompletedSweat Sodium ConcentrationUnited States
-
San Diego State UniversityCompleted
-
PepsiCo Global R&DCompleted
-
Kind Lab PBC.CitruslabsCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
USDA, Western Human Nutrition Research CenterUniversity of California, DavisCompletedStability & Variability of Lipid-derived Molecules in SweatUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedThe Sweat Alcohol Concentration
Clinical Trials on Low intensity
-
Robert Ross, PhDRecruiting
-
Virginia Polytechnic Institute and State UniversityEnrolling by invitation
-
University of California, BerkeleyUniversity of California, San FranciscoCompleted
-
Virginia Polytechnic Institute and State UniversitySalem VA Medical Center; Washington DC VA Medical CenterRecruitingChronic Pain | Opioid Use Disorder | Anxiety DisorderUnited States
-
Virginia Polytechnic Institute and State UniversityActive, not recruiting
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Virginia Polytechnic Institute and State UniversityEnrolling by invitation
-
Chongqing Medical UniversityRecruitingThe Therapeutic Effect of Low-intensity Focused Ultrasound on Painful Diabetic Peripheral NeuropathyPainful Diabetic NeuropathyChina
-
Kessler FoundationNational Cancer Institute (NCI); Kessler Institute for RehabilitationCompletedBreast CancerUnited States
-
Carilion ClinicVirginia Polytechnic Institute and State UniversityRecruitingChronic Pain | Fibromyalgia | Complex Regional Pain SyndromesUnited States